Drug intelligence / Profile preview

lidocaine + adrenaline

Development stage
Unknown
Lead developer
Dow University of Health Sciences
Modality
Small Molecules
Administration
Topical
01

Overview

Lidocaine + adrenaline is a combination of the local anesthetic lidocaine (2%) and the vasoconstrictor adrenaline (epinephrine, 1:100,000) used as a topical intervention. Developed for clinical study by Dow University of Health Sciences, it is applied via soaked gauze to skin graft donor sites, particularly on the thigh, in patients with non-healing wounds or burns requiring split-thickness skin grafting. Lidocaine provides analgesia by blocking voltage-gated sodium channels, while adrenaline induces local vasoconstriction through adrenergic receptor agonism. This dual action aims to minimize perioperative bleeding, reduce the frequency of dressing changes, and alleviate postoperative pain within the first 24 hours of skin graft harvesting.

Brand names
ORA Injection
Other names
2% Lidocaine and 1:100,000 AdrenalineLidocaine and Adrenaline Soaked Gauzelidocaine and epinephrine
02

Targets

ADRB1 (β1)ADRA1A (α1A)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on lidocaine + adrenaline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lidocaine + adrenaline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call